Consolidated Statements Of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 163,962	$ 343,371
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	80,548	71,762
Earnings of equity method investments, net of distributions	1,363	628
Loss on early extinguishment of debt attributable to unamortized discount	(1,489)	0
Deferred income taxes	(5,679)	(20,533)
Equity based compensation expense	6,186	8,580
Change in fair value - derivative instruments	(10,546)	(53,745)
(Increase) decrease in current assets:
Accounts receivable	17,878	(22,294)
Inventories	(236,045)	(151,168)
Income taxes receivable	96,945	37,053
Prepayments and other	10,010	3,866
Increase (decrease) in current liabilities:
Accounts payable	260,834	(40,964)
Income taxes payable	0	151,403
Accrued liabilities	3,060	(9,846)
Turnaround expenditures	(4,292)	(69,835)
Other, net	9,216	285
Net cash provided by operating activities	394,929	248,563
Cash flows from investing activities:
Additions to properties, plants and equipment	(103,677)	(66,951)
Proceeds from sale of properties, plants, and equipment	0	2,290
Investment in Sabine Biofuels	(1,000)	0
Net repayment of advances to Sabine Biofuels	2,586	0
Purchases of marketable securities	(244,030)	(178,251)
Sales and maturities of marketable securities	(253,676)	(143,280)
Net cash used for investing activities	(113,049)	(104,645)
Cash flows from financing activities:
Proceeds from sale of HEP common units	0	73,444
Proceeds from common unit offerings - HEP	0	146,888
Inventory repurchase obligation	21,126	0
Purchase of treasury stock	(13,988)	(6,610)
Dividends	(158,614)	(102,163)
Excess tax benefit from equity based compensation	5,156	744
Deferred financing costs and other	(323)	(2,973)
Net cash used for financing activities	(147,348)	(29,175)
Cash and cash equivalents:
Increase for the period	134,532	114,743
Beginning of period	940,103	1,757,699
End of period	1,074,635	1,872,442
Cash paid during the period for:
Interest	20,469	20,825
Income taxes	233	17,380
HEP [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,184	13,749
Cash flows from investing activities:
Additions to properties, plants and equipment	(20,604)	(5,013)
Cash flows from financing activities:
Borrowings under credit agreement - HEP	421,300	57,000
Repayments under credit agreement - HEP	(246,600)	(110,000)
Redemption of senior notes	(156,188)	0
Proceeds from common unit offerings - HEP		73,444
Distributions to noncontrolling interest	(18,881)	(15,288)
Purchase of units for incentive grants - HEP	(336)	(2,719)
Cash and cash equivalents:
Beginning of period	6,352
End of period	4,879
Guarantor Restricted Subsidiaries Member
Cash flows from operating activities:
Net income	262,359	550,910
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	67,107	60,620
Increase (decrease) in current liabilities:
Net cash provided by operating activities	381,180	282,983
Cash flows from investing activities:
Additions to properties, plants and equipment	(100,483)	(65,215)
Proceeds from sale of properties, plants, and equipment		0
Investment in Sabine Biofuels	(1,000)
Net repayment of advances to Sabine Biofuels	2,586
Purchases of marketable securities	0	0
Sales and maturities of marketable securities	0	0
Net cash used for investing activities	(401,670)	(289,882)
Cash flows from financing activities:
Proceeds from common unit offerings - HEP		0
Inventory repurchase obligation	21,126
Purchase of treasury stock	0	0
Dividends	0	0
Distributions to noncontrolling interest	0	0
Excess tax benefit from equity based compensation	0	0
Purchase of units for incentive grants - HEP	0
Deferred financing costs and other	(398)	(3,247)
Net cash used for financing activities	20,728	3,247
Cash and cash equivalents:
Increase for the period	238	(3,652)
Beginning of period	1,817	3,652
End of period	2,055	0
Guarantor Restricted Subsidiaries Member | HEP [Member]
Cash flows from investing activities:
Additions to properties, plants and equipment	0	0
Cash flows from financing activities:
Purchase of units for incentive grants - HEP		$ 0